Skip to main content
Premium Trial:

Request an Annual Quote

Struck by Slight Subversion

Premium

I read your recent editorial and would like to make a few comments, with the cloak of anonymity. I have been working in startup biotech companies for over 10 years. I live in the Bay Area and have a number of friends in the biotech industry. I read a number of different journals, and recently discovered your magazine.

I was immediately struck by the interesting mixture of technological information, business articles, and gossip. It is a good mix. What a refreshing change to read about people speaking openly of layoffs in a trade journal. Other journals tend to ignore or whitewash the cutthroat aspects of the industry, but you don’t and that is what makes your magazine interesting and unique.

You should continue with your open and slightly subversive style, applying it to the biotech industry as a whole. No need to limit yourself to just genomics.

Name withheld

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.